Linear Accelerator Replacement

Halifax Health is requesting bids for the replacement of an existing linear accelerator within the Charles L. and Miki N. Grant Cancer Center for Hope at its Daytona Beach Campus, with proposals due September 25, 2026 at 12:00 PM EST and a mandatory pre-bid meeting on September 15, 2026 at 11:00 AM.

The scope is a complete turnkey installation project including removal of existing linear accelerator equipment, installation of owner-provided Elekta linear accelerator equipment, and all associated mechanical, electrical, and infrastructure modifications required for operational readiness. Work must be performed within an active healthcare environment with demonstrated experience maintaining safety and infection prevention protocols. Contractors must provide equipment brands and models with justifications, all materials, labor, supervision, permits, and installation methods as a single total project cost.

The successful bidder will be the lowest responsive and responsible bidder whose offer is most advantageous to Halifax Health's interests. Halifax Health reserves the right to award to a single bidder or divide the award among multiple bidders. The bidder must provide Performance Bond and Payment Bond each equal to 100 percent of the total contract price, issued by a Florida-authorized surety, or alternative security (cash or irrevocable letter of credit). Comprehensive insurance is required with minimums of $1.5 million per occurrence and $250,000 aggregate for bodily injury and property damage liability, plus workers' compensation coverage. All employees require criminal background checks through the Florida Department of Law Enforcement and must obtain ID badges before work commences.

Payment terms are NET 45 days following hospital acceptance under the Florida Statutes 218.74 Local Government Prompt Payment Act. Contractors must maintain the work free from defects for one year following final acceptance and payment. Questions are due September 18, 2026 at 12:00 PM EST, with a Q&A addendum anticipated September 21. The Notice of Intent to Award is anticipated October 5, 2026.